KJ Bio A/S: Financial statements 2023
CVR: 40352104
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
KJ Bio A/S (CVR 40352104) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -135,339 and a net result of DKK -559,828 compared with DKK -525,745 the year before. Equity in the 2023 report amounted to DKK -501,018. The company had 1 employee in the financial year.
- Gross Profit
- DKK -135,339
- Profit/Loss
- DKK -559,828
- Equity
- DKK -501,018
- Total Assets
- DKK 223,388
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -135K | -560K | -501K | 1 |
| 2022 | - | -123K | -526K | 59K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout KJ Bio A/S
KJ Bio A/S was a Danish company of the type Aktieselskab based in Hinnerup, founded in 2019. The company has been dissolved on 29 April 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named TGOD Genetics A/S. The company has 1 employee (2023). In 2024, the company reported a gross profit of DKK -51,660 and a net result of DKK -106,521 compared with DKK -559,828 the year before. Equity in the 2024 report amounted to DKK -607,539.